Researchers say ‘relatively simple, inexpensive’ means of assessing genetic risk offers hope of better screeningAn at-home spit test appears to perform better at predicting prostate cancer risk than the current frontline test, a study suggests.The test assesses 130 genetic variants to provide a risk score for prostate cancer, which is the second most common cause of cancer deaths in men in the UK. Continue reading...